Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.1.1.u2
Stock-Based Compensation (Tables)
12 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
Total stock-based compensation expense consists of the following:
 
Years Ended 31 March
(Millions of US dollars) 2024 2023 2022
Liability Awards $ 17.3  $ 2.7  $ 3.2 
Equity Awards 28.2  15.7  9.0 
Total stock-based compensation expense $ 45.5  $ 18.4  $ 12.2 
Summary of Stock Options Available for Grant
The following table summarizes the Company’s shares available for grant as options, RSUs or other equity instruments under the LTIP and 2001 Plan:
 
Shares
Available for
Grant
Balance at 31 March 2022
21,489,696 
Granted (2,540,893)
Balance at 31 March 2023
18,948,803 
Granted (1,169,733)
Balance at 31 March 2024
17,779,070 
Schedule of Stock Options Roll Forward
The following table summarizes the Company’s stock options activity during the noted period:
Outstanding Options
Number of Options Weighted Average
Exercise Price (A$)
Balance at 31 March 2022
—  — 
Granted 269,221  33.05 
Balance at 31 March 2023
269,221  33.05 
Granted —  — 
Balance at 31 March 2024
269,221  33.05 
Options exercisable at 31 March 2024
—  — 
Restricted Stock Unit Activity
The following table summarizes the Company’s RSU activity:
(Units) Service
Vesting
(2001 Plan)
Performance
Vesting
(LTIP)
Market
Conditions (LTIP)
Total Weighted
Average Fair
Value at Grant
Date (A$)
Outstanding at 31 March 2022
414,675  291,704  494,033  1,200,412  27.83 
Granted 1,279,127  268,009  724,536  2,271,672  26.12 
Vested (449,458) (87,307) (256,787) (793,552) 25.17 
Forfeited (107,818) (100,377) (91,738) (299,933) 28.46 
Outstanding at 31 March 2023
1,136,526  372,029  870,044  2,378,599  26.97 
Granted 533,278  176,624  459,831  1,169,733  43.20 
Vested (373,440) (90,452) (42,581) (506,473) 30.88 
Forfeited (68,712) (13,299) (173,643) (255,654) 25.63 
Outstanding at 31 March 2024
1,227,652  444,902  1,113,651  2,786,205  33.36 
Assumptions Used to Fair Value Restricted Stock Grants
The following table includes the assumptions used to fair value the RSU grants (market condition):
Vesting Condition: Market Market Market Market Market Market Market Market
  FY24 FY24 FY23 FY23 FY23 FY23 FY23 FY23
Date of grant 1-Sep-23 1-Sep-23 13-Mar-23 3-Nov-22 3-Nov-22 3-Nov-22 31-Aug-22 31-Aug-22
Dividend yield (per annum) —  % —  % —  % —  % —  % —  % 1.5  % 1.5  %
Expected volatility 35.4  % 38.7  % 36.3  % 42.5  % 35.1  % 43.8  % 41.9  % 33.4  %
Risk free interest rate 4.6  % 4.9  % 4.0  % 4.7  % 4.7  % 4.7  % 3.5  % 3.5  %
Expected life in years 3.0 2.0 2.4 0.8 1.8 2.8 3.0 2.0
JHX stock price at grant date (A$) 46.72 46.72 30.98 33.05 33.05 33.05 33.51 33.51
Number of restricted stock units 451,945 7,886 41,401 38,387 39,450 115,688 387,360 102,250
Schedule of Fair Value of Restricted Stock Units Vested
The following table presents the total fair value of all of our restricted stock units vested:
Years ended 31 March
(Millions of US dollars) 2024 2023 2022
Total fair value vested $ 16.1  $ 18.4  $ 42.6 
Cash Settled Units Activity
The following represents the activity related to the CSUs:
FY24 FY23
Granted 529,875  751,569 
Vested 177,955  237,600 
Cancelled 125,144  325,459